Friday, September 14, 2012

Lundbeck/Otsuka Seeks FDA OK For Depot Version of Aripiprazole

Lundbeck/Otsuka is going to resubmit an FDA NDA for a depot formulation of aripiprazole. (Abilify) Looks like there were problems with the initial submission.
And the FDA submission isn't the Only problem Lundbeck/Otsuka and the Consumers are going to have with aripiprazole either.
Notice the Ad speaks of Antidepressants, when Abilify is Not an Antidepressant. It's an Antipsychotic.
But the Lundbeck/Otsuka depot formulation won’t have those nasty side effects like the BMS version of aripiprazole. We’ll Know those side effects aren’t a problem because all the Lundbeck/Otsuka, ahhhm, …..  prescribing Ladies of the Night will choke and turn blue rather than Admit that there are such side effects.
Go on, Click on the Link. You know you want to.

And we simply Can't have anyone being "non-compliant" with Doctor's Orders. So if those nutters Refuse to voluntarily swallow the Shite Daily, now Lundbeck/Otsuka will have a Depot formulation to handle the problem.  

Those scary, nasty, ooo-ky, nutters, ..... Hey, You might even be one, .... have to be Controlled. We can't just go around allowing undiagnosed and un-drugged Mood Disorders to, well, ..... happen. 

And if you like This sampler, you'll also like the Next group.

Faces of 'Mental Health' A Pictorial Essay

No comments: